Skip to main content

Table 3 Correlation between AMH levels and some clinical and biochemical parameters. The number of pairs evaluated is reported in brackets

From: Cross-sectional and prospective study on anti-Müllerian hormone changes in a cohort of pre-menopausal women with a history of differentiated thyroid cancer

 Group 1Group 2Group 3
SrPSrPSrP
Age−0.71 (59)< 0.0001− 0.72 (30)< 0.0001− 0.62 (141)< 0.0001
Years since diagnosis− 0.20 (59)0.140.03 (30)0.89n.a.n.a.
RAI activity−0.11 (59)0.38n.a.n.a.n.a.n.a
BMI0.02(59)0.840.05 (30)0.810.01 (132)0.93
L-T4 dosage/week0.13 (59)0.32−0.11 (30)0.55n.an.a
TSH−0.04 (59)0.780.16 (30)0.400.14 (121)0.12
f-T40.06 (59)0.650.32 (30)0.09−0.13 (105)0.19
Thyroglobulin−0.05 (59)0.780.04 (30)0.81n.an.a.
FSH−0.55 (56)< 0.0001−0.77 (30)< 0.0001− 0.46 (102)< 0.0001
Estradiol−0.13 (54)0.350.20 (28)0.30−0.16 (98)0.12
Progesterone0.28 (52)0.050.28 (26)0.16−0.18 (85)0.09
PRL0.09 (57)0.520.09 (26)0.68−0.11 (97)0.26
  1. n.a. Not applicable